Management of hypertension in advanced kidney disease

Panagiotis I Georgianos1, Rajiv Agarwal2

  • 1Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Insights

Newer therapies improve hypertension management in advanced chronic kidney disease (CKD). Potassium binders aid spironolactone use, novel nonsteroidal mineralocorticoid receptor antagonists (MRAs) show promise, and chlorthalidone effectively lowers blood pressure.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Hypertension is a significant complication in patients with advanced chronic kidney disease (CKD).
  • Managing blood pressure in CKD patients is challenging due to risks of hyperkalemia and reduced drug efficacy.

Purpose of the Study:

  • To review recent advancements in pharmacotherapy for hypertension in patients with advanced CKD.
  • To highlight novel therapeutic strategies for improved blood pressure control in this high-risk population.

Main Methods:

  • Review of recent clinical trials including AMBER, BLOCK-CKD, and CLICK.
  • Analysis of pharmacologic interventions targeting blood pressure and potassium levels in CKD patients.

Main Results:

  • Patiromer, a potassium binder, facilitated spironolactone use and improved blood pressure control in patients with resistant hypertension and advanced CKD.
  • The novel nonsteroidal mineralocorticoid receptor antagonist (MRA) KBP-5074 demonstrated significant blood pressure reduction with minimal hyperkalemia risk in advanced CKD.
  • Chlorthalidone, a thiazide-like diuretic, effectively lowered 24-hour ambulatory systolic blood pressure in patients with stage 4 CKD and uncontrolled hypertension.

Conclusions:

  • New potassium-binding agents enable more consistent spironolactone therapy.
  • Novel nonsteroidal MRAs offer a potentially improved benefit-risk profile for hypertension management in advanced CKD.
  • Chlorthalidone presents a viable option for blood pressure reduction in high-risk CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
53
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
55
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
41
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
36
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
41